MDT · Categories · Downgrades
MDT - Analyst downgrades
Medtronic plc. (MDT) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for MDT
- Medtronic downgraded by Stifel with a new price targetStifel downgraded Medtronic from Buy to Hold and set a new price target of $85.00 from $100.00 previously
- Medtronic downgraded by UBS with a new price targetUBS downgraded Medtronic from Buy to Sell and set a new price target of $79.00 from $127.00 previously
- Medtronic downgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts downgraded Medtronic from Outperform to Sector Perform and set a new price target of $89.00 from $102.00 previously
- Medtronic downgraded by Citigroup with a new price targetCitigroup downgraded Medtronic from Buy to Neutral and set a new price target of $85.00 from $108.00 previously
- Medtronic downgraded by Oppenheimer with a new price targetOppenheimer downgraded Medtronic from Outperform to Perform and set a new price target of $85.00 from $106.00 previously
- Medtronic downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded Medtronic from Buy to Hold and set a new price target of $85.00
- Medtronic downgraded by Raymond JamesRaymond James downgraded Medtronic from Outperform to Mkt Perform
- Medtronic downgraded by Atlantic Equities with a new price targetAtlantic Equities downgraded Medtronic from Overweight to Neutral and set a new price target of $105.00 from $125.00 previously
- Medtronic downgraded by NeedhamNeedham downgraded Medtronic from Buy to Hold
- Medtronic downgraded by Truist with a new price targetTruist downgraded Medtronic from Buy to Hold and set a new price target of $121.00 from $124.00 previously
- Medtronic downgraded by BTIGBTIG downgraded Medtronic from Buy to Neutral
- Medtronic downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Medtronic from Overweight to Equal-Weight and set a new price target of $120.00 from $145.00 previously
- Medtronic downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Medtronic from Overweight to Neutral and set a new price target of $110.00 from $152.00 previously
- Medtronic downgraded by JP Morgan with a new price targetJP Morgan downgraded Medtronic from Overweight to Neutral and set a new price target of $105.00 from $130.00 previously
- Medtronic downgraded by Wells Fargo with a new price targetWells Fargo downgraded Medtronic from Overweight to Equal-Weight and set a new price target of $110.00